Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib

Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib

We investigated the effects of the cholesteryl ester (CE) transfer protein inhibitor anacetrapib (ANA) on plasma lipids, lipoprotein subfraction concentrations, and lipoprotein composition in 30 healthy individuals. Participants (n = 30) were randomized to ANA 20 mg/day, 150 mg/day, or placebo for 2...

Full description

Bibliographic Details
Main Authors: Ronald M. Krauss, Kathleen Wojnooski, Joseph Orr, J. Casey Geaney, Cathy Anne Pinto, Yang Liu, John A. Wagner, Julie Mabalot Luk, Amy O. Johnson-Levonas, Matt S. Anderson, Hayes M. Dansky
Format: Article
Language:English
Published: Elsevier 2012-03-01
Series:Journal of Lipid Research
Subjects:
cholesteryl ester transfer protein inhibitor
lipid
low density lipoprotein
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520413690

Internet

http://www.sciencedirect.com/science/article/pii/S0022227520413690

Similar Items